Advances in DNA and mRNA-Based Strategies for Cancer Immunotherapy: Part A

Erscheinungsjahr 2025
ISBN: 978-0-443-34495-4
Verlag: Elsevier Science & Technology

Buch, Englisch, Format (B × H): 152 mm x 229 mm, Gewicht: 450 g

Advances in DNA and mRNA-Based Strategies for Cancer Immunotherapy, Volume 165 in the Advances in Immunology series, presents current developments and comprehensive reviews in DNA and mRNA vaccines: Significant therapeutic approach against cancer management, Nanoparticles for mRNA-based cancer immunotherapy, Nucleic acid Delivery as a therapeutic approach in cancer immunotherapy, Plasmid DNA and mRNA: Delivery approaches and challenges, Viral & Non-viral Delivery of mRNA against Cancer Cell, Progress in Modifying and Delivering mRNA therapies for Cancer Immunotherapy, and more.

Other chapters cover mRNA-Based Cancer Vaccines: A Novel Approach to Melanoma Treatment, Therapeutic mRNAs for cancer immunotherapy: from structure to delivery, Harnessing the immune system: Insights into cancer vaccines, Lipid Nanoparticle-Mediated mRNA Delivery in Cancer Immunotherapy, Immunotherapy Perspectives in the Era of B-Cell Editing in Cancer Treatment, Personalized Precision: Revolutionizing Cancer Treatment with mRNA-Based Vaccines in Melanoma Therapy, Revolutionizing Cancer Treatment: Exploring Novel Immunotherapeutics, Checkpoints, bispecifics, and Vaccines in Development, and more.

Autoren/Hrsg.

Weitere Mitwirkende

Singh, Arun Kumar

Ashique, Sumel

Prabhakar, Pranav Kumar

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Immunologie

Inhaltsverzeichnis

1. DNA and mRNA vaccines: Significant therapeutic approach against cancer management

Aniruddha Sen, Vijay Singh, Sumel Ashique, Jagriti, Sombuddha Biswas, Anas Islam,

Iman Ehsan, and Naheed Mojgani

2. Nucleic acid delivery as a therapeutic approach for cancer immunotherapy

Kashish Wilson, Garima, and Meenakshi Dhanawat

3. Plasmid DNA and mRNA Delivery: Approaches and Challenges

Arun Kumar Singh, Karan Goel, and Meenakshi Dhanawat

4. Viral & non-viral delivery of mRNA against cancer

Ece Guler, Humeyra Betul Yekeler, Muhammet Emin Cam, and Burcu Uner

5. Progress in modifying and elivering mRNA therapies for cancer immunotherapy

Karan Goel, Isha Chawla, Garima, Meenakshi Dhanawat, and Pramila Chaubey

6. mRNA-based cancer vaccines: A novel approach to melanoma treatment

Pranav Kumar Prabhakar, Tarun Kumar, Upadhyaya, and

Sanjeev Kumar Sahu

7. Therapeutic mRNAs for cancer immunotherapy: From structure to delivery

Monika Vishwakarma, Wasim Akram, and Tanweer Haider

Über Autor(innen)

Singh, Arun Kumar
Arun Kumar Singh has completed M. Pharm (Pharmaceutics) from Galgotias University, Greater Noida, India. Mr. Singh joined as an assistant professor in the Department of Pharmacy, Vivekanand Global University Jaipur Rajasthan 303012. His area of interest is in the area of Nano-formulation, Blockchain, IoT, Machine learning, Cancer, Artificial intelligence, Big data, and Neuroscience. He has authored one book with IOP publishing. He has published 5 chapters in big data with the prestigious River Publisher, in Denmark. He has also published 20 review papers among which two are in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. He has published 26 books with different publishers like IOP, Elsevier, CRC PRESS, and Wiley. His strengths are research skills, innovation, leadership, decision-making, and positive thinking. His hard-working nature and devotion to their work make him distinguishable and extraordinary.

Ashique, Sumel
Sumel Ashique has been working as an assistant professor at Bengal College of Pharmaceutical Sciences & Research, Durgapur 713212, West Bengal, India, West Bengal, India. He has 3.5 years of teaching experience. He has achieved 70+ publications of International and national accredited reputed journals (Scopus, UGC). He has knowledge in drug delivery, nanotechnology and targeted treatment strategy. He has also 6 granted patents from IP and Australia & 20 book chapters have been submitted to well-known publishers like Springer, Elsevier, Bentham and Taylor & Francis. Currently he is editing 13 books under CRC Press, Taylor & Francis, Springer and Wiley.

Prabhakar, Pranav Kumar
Dr. Pranav Kumar Prabhakar is currently working as a Professor in the Department of Biotechnology at Nagaland University, Kohima, Nagaland, India. He has been listed among the World's Top 2% Scientists (as published by Stanford University, USA, in 2021, 2022, 2023, and 2024). He earned his PhD in Biotechnology from IIT Madras. His primary research interests include elucidating molecular mechanisms and strategies for oral insulin delivery and mimicking signaling pathways in metabolic disorders (diabetes) using natural products. He is a member of the Royal Society of Chemistry and the Asia-Pacific Chemical, Biological & Environmental Engineering Society. He also serves as an editorial board member and reviewer for several reputed national and international journals. Dr. Pranav has received various honors, including a travel grant to attend ATTD 2009 in Greece, sponsored by the Indian Institute of Technology Madras and the Council for Scientific and Industrial Research (CSIR), and approved by the Department of Science and Technology (DST). He has published over 115 research articles in journals, authored or edited 17 books, contributed more than 40 book chapters, and delivered 9 oral and poster presentations at scientific meetings.